Bill Greene, Pharm.D., BCPS, FASHP, chief pharmaceutical officer at St. Jude Children’s Research Hospital in Memphis, stressed the need for immediate action to solve the ongoing drug shortage crisis during a hearing last Thursday held by the health subcommittee of the House of Representatives Energy and Commerce Committee.
ASHP submitted a statement for the record to the subcommittee that provided examples of policy options that Congress should pursue to alleviate drug shortages, including the early warning system included in H.R. 2245, The Preserving Access to Life-Saving Medications Act. The Society also advocated examining the impact of the Drug Enforcement Administration’s (DEA’s) quota system on shortages of controlled drugs and inclusion of a generic drug user fee in the reauthorization of the Prescription Drug User Fee Act (PDUFA) for use as economic incentives for manufacturers.
Public Relations Division
Stay connected with ASHP through our social media tools.
What We Do
For the Press
Jobs at ASHP
AHFS Drug Information
Customer Service: 1-866-279-0681
8:00am - 6:00pm ET, Mon-Fri
American Society of Health-System Pharmacists. All rights reserved. 7272 Wisconsin Avenue, Bethesda, MD 20814